Paper2643085
p36C: an improved baculovirus expression vector for producing high levels of mature recombinant proteins.
Page MJ. Nucleic Acids Res, 1989. Cited by 29 papers, by iCite.
Cite this record
ConductScience Library. p36C: an improved baculovirus expression vector for producing high levels of mature recombinant proteins. Papers, record 2643085. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2643085
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- p36C: an improved baculovirus expression vector for producing high levels of mature recombinant proteins.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Genetic Vectors | Major topic |
| Insect Viruses | Major topic |
| Recombinant Proteins | Major topic |
| Amino Acid Sequence | |
| Base Sequence | |
| Genes | |
| Genes, Viral | |
| Molecular Sequence Data | |
| Occlusion Body Matrix Proteins | |
| Viral Proteins | |
| Viral Structural Proteins |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35121872 | The immuno-oncological challenge of COVID-19. | Nat Cancer | 2020 | https://conductscience.org/library/papers/35121872 | PubMed |
| 8657148 | Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction. | Mol Cell Biol | 1996 | https://conductscience.org/library/papers/8657148 | PubMed |
| 8265591 | Transcriptional regulation of HLA-A and -B: differential binding of members of the Rel and IRF families of transcription factors. | Proc Natl Acad Sci U S A | 1993 | https://conductscience.org/library/papers/8265591 | PubMed |
| 2395882 | Inhibition of estrogen receptor-DNA binding by the "pure" antiestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization. | Proc Natl Acad Sci U S A | 1990 | https://conductscience.org/library/papers/2395882 | PubMed |
| 2247075 | Mechanism of estrogen receptor-dependent transcription in a cell-free system. | Mol Cell Biol | 1990 | https://conductscience.org/library/papers/2247075 | PubMed |
| 2019434 | Synthesis of tetanus toxin fragment C in insect cells by use of a baculovirus expression system. | Infect Immun | 1991 | https://conductscience.org/library/papers/2019434 | PubMed |
| 1741284 | Highly efficient generation of recombinant baculoviruses by enzymatically medicated site-specific in vitro recombination. | Nucleic Acids Res | 1992 | https://conductscience.org/library/papers/1741284 | PubMed |
| 1461749 | Enhanced expression of recombinant proteins in insect cells using a baculovirus vector containing a bacterial leader sequence. | Nucleic Acids Res | 1992 | https://conductscience.org/library/papers/1461749 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2643085
GET https://conductscience.org/api/papers/v1/2643085/authors